| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Coo/ CFO | Chief Financial Officer
2 companies
Giraudo Bryan is a Coo/ CFO at Gossamer Bio, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2019 | PTGX Protagonist Therapeutics, Inc | Director | Buy | 8,000 | $5.70 | $45,620.00 | New | |
| Sep 26, 2019 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 1,121 | $16.78 | $18,810.16 | +112.1% | |
| May 30, 2019 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 1,000 | $18.70 | $18,700.00 | New | |
| Feb 12, 2019 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 6,000 | $16.00 | $96,000.00 | +33.6% | |
| May 16, 2017 | PTGX Protagonist Therapeutics, Inc | Director | Buy | 10,000 | $6.46 | $64,566.00 | New |